Key Highlights
- Shares of Rocket Lab reached a fresh 52-week peak of $105.62 following TD Cowen’s price target increase from $90 to $120 with a Buy rating maintained
- First quarter 2026 revenue hit a record $200.3 million, representing approximately 63% growth compared to the same period last year and surpassing analyst projections
- Second quarter revenue outlook increased to a range of $225–$240 million, suggesting sequential expansion of roughly 16%
- The company’s total backlog surged to an all-time high of $2.2 billion, doubling year-over-year, with launch services representing 42% and space systems accounting for 58%
- Major announcements included a $30 million hypersonic HASTE program contract with Anduril and the strategic acquisition of robotics company Motive Space Systems
Shares of Rocket Lab (RKLB) exploded higher by 34% during Friday’s trading session, finishing at $105.55 after touching a new 52-week high of $105.62 — a dramatic climb from the previous closing price of $78.58. Trading volume surged to 76 million shares, approximately 247% above the three-month daily average.
The dramatic price surge followed an impressive first quarter 2026 earnings release. The aerospace company reported record revenue of $200.3 million, marking a 63% increase compared to the prior year period and exceeding Wall Street projections. The loss per share narrowed to $0.07, also outperforming analyst estimates.
TD Cowen acted swiftly following the results. The investment firm lifted its price objective on RKLB shares from $90 to $120 while reiterating its Buy recommendation, providing additional momentum to an already powerful rally.
The excitement extended well beyond the top-line figures. Rocket Lab’s total backlog expanded 108% to reach a record $2.2 billion. The composition reveals increasing diversification, with launch services comprising 42% and space systems making up 58% of the total.
Executives also elevated their second quarter revenue forecast to a range of $225 million to $240 million. This projection would establish another quarterly record and represents approximately 16% growth on a sequential basis.
Strategic Wins and Defense Partnerships
Beyond the impressive financial results, Rocket Lab unveiled multiple strategic agreements that reinforce its growth trajectory.
The aerospace firm secured what it described as the largest launch agreement in company history, encompassing multiple missions using both Neutron and Electron vehicles for a customer that was not disclosed. This contract significantly enhances revenue predictability for an already expanding order book.
Rocket Lab also captured a $30 million HASTE hypersonic launch program award in partnership with Anduril Industries. This collaboration connects two prominent players in the emerging defense technology sector.
An additional Space Force demonstration agreement with Raytheon was revealed, further validating the strong demand for Rocket Lab’s launch services within the defense market.
During the quarter, Rocket Lab completed the acquisition of Motive Space Systems, a space robotics company, a strategic transaction that could expand the company’s capabilities in future space exploration initiatives.
Wall Street Perspectives
The analyst community maintains a generally optimistic stance, though opinions vary. Roth MKm increased its price objective from $90 to $100 ahead of the earnings release while maintaining a Buy rating. Cantor Fitzgerald kept its Overweight stance with an $85 target back in March.
Conversely, Wells Fargo launched coverage in April with an Equal Weight recommendation and a $60 price target — substantially below current trading levels. KeyCorp moved RKLB to Sector Weight in January.
According to MarketBeat data, the consensus rating stands at “Moderate Buy” with an average price target of $90. This consensus figure now significantly trails the stock’s actual price following Friday’s substantial rally.
Insider transactions have leaned toward selling recently. Chief Financial Officer Adam Spice divested approximately 62,744 shares at $69.59 during March. Frank Klein, another insider, sold 36,768 shares at $71.95 around the same timeframe. Total insider sales over the previous 90-day period reached roughly 233,449 shares valued at approximately $16.5 million.
Institutional investors hold 71.78% of outstanding shares. The stock’s 50-day moving average currently stands at $72.88 while the 200-day average registers at $68.50, both now substantially below present trading levels.
Following Friday’s surge, Rocket Lab’s market capitalization now stands at approximately $61 billion.
